Showing results (481-490 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|August 14, 2020
CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignanciesBlake J Rust, Hans-Peter Kiem, Thomas S Uldrick
The Lancet. Haematology|May 4, 2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumoursCristina Nanni, Carsten Kobe, Bettina Baeßler, et al.
The Lancet. Haematology|June 27, 2020
Machine learning in haematological malignanciesNathan Radakovich, Matthew Nagy, Aziz Nazha
The Lancet. Haematology|April 24, 2021
Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialBart J Biemond, Anil Tombak, Yurdanur Kilinc, et al.
The Lancet. Haematology|July 14, 2020
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort studyDanying Liao, Fen Zhou, Lili Luo, et al.
The Lancet. Haematology|August 1, 2020
Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysisNicholas D Klemen, Paul L Feingold, Barry Hashimoto, et al.
The Lancet. Haematology|November 10, 2022
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysisKainat Saleem, Joseph Franz, Mary Lou Klem, et al.
The Lancet. Haematology|November 12, 2022
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trialJustin M Watts, Maria R Baer, Jay Yang, et al.
The Lancet. Haematology|March 27, 2023
Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort studyHanke M G Wiegers, Dóra Körmendiné Farkas, Erzsébet Horváth-Puhó, et al.
The Lancet. Haematology|May 30, 2020
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trialsSaad Z Usmani, Hareth Nahi, Torben Plesner, et al.
Pageof 73